# Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery

> **NCT05392634** · PHASE3 · UNKNOWN · sponsor: **N.N. Petrov National Medical Research Center of Oncology** · enrollment: 98 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Meropenem 1000 mg
- **DRUG:** Amoxicillin+clavulanic acid 1200 mg or Cefuroksim 1500mg

## Key facts

- **NCT ID:** NCT05392634
- **Lead sponsor:** N.N. Petrov National Medical Research Center of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-02
- **Primary completion:** 2023-02-02
- **Final completion:** 2023-11-01
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2022-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392634, "Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05392634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*